There are a plethora of unqualified phone, tablet, and battery manufacturers in China, but the country has just implemented new legislation aimed at taking many of them off the market.
The GB 31241-2014 regulation states that all lithium-ion cells and batteries, as well as the devices that run them, must be brought to authorized laboratories to be tested. These items can then be certified by approved government bodies to be sold to the public.
Lithium batteries, as I’ve mentioned here before, (and then again here) are part of a fast-growing global market — and nowhere are they more important than in China, where the switch to clean energy is an immediate issue.
Remember, the country’s past record of high emissions has put pressure on it to cut down the air pollution — and lithium batteries are a very easy way to achieve this!
Understand that not only are these batteries completely pollution-free, but they offer higher voltage and energy density, meaning they can last longer and require less maintenance.
In China, lithium batteries are being used in phones, laptops, digital cameras, and increasingly personal and commercial vehicles.
Of course, the quality of the battery is of the utmost importance; incorrectly designed lithium batteries can catch fire and even explode, which can directly lead to a loss of property at best and a loss of life at worst.
So as lithium technology grows and flourishes, so too will the regulations deeming it safe for the public.
One major Chinese company, Shenzhen NTEK Testing Technology Co., Ltd., has already been granted the certification to test lithium-ion batteries for GB 31241-2014 adherence. The company now has the ability to approve batteries for Chinese CQC certificates, as well as Indian BIS and South Korean KC certificates.
To continue reading…
Until next time,
A true insider in the technology and energy markets, Keith’s research has helped everyday investors capitalize from the rapid adoption of new technology trends and energy transitions. Keith connects with hundreds of thousands of readers as the Managing Editor of Energy & Capital, as well as the investment director of Angel Publishing’s Energy Investor and Technology and Opportunity.
For nearly two decades, Keith has been providing in-depth coverage of the hottest investment trends before they go mainstream — from the shale oil and gas boom in the United States to the red-hot EV revolution currently underway. Keith and his readers have banked hundreds of winning trades on the 5G rollout and on key advancements in robotics and AI technology.
Keith’s keen trading acumen and investment research also extend all the way into the complex biotech sector, where he and his readers take advantage of the newest and most groundbreaking medical therapies being developed by nearly 1,000 biotech companies. His network includes hundreds of experts, from M.D.s and Ph.D.s to lab scientists grinding out the latest medical technology and treatments. You can join his vast investment community and target the most profitable biotech stocks in Keith’s Topline Trader advisory newsletter.